A possible role for ST2 as prognostic biomarker for COVID-19
Rosetta Ragusa, Giuseppina Basta, Serena Del Turco, Chiara Caselli
Topics & Concepts
ARDSBiomarkerMedicineAsymptomaticCytokine stormCoronavirus disease 2019 (COVID-19)DiseaseSepsisSystemic inflammationPathophysiologyPulmonary fibrosisInternal medicineInflammationSeverity of illnessImmunologyFibrosisLungInfectious disease (medical specialty)ChemistryBiochemistryIL-33, ST2, and ILC PathwaysAir Quality and Health ImpactsInflammasome and immune disorders